Elinzanetant for Vasomotor symptoms [ID6544]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: 21 July 2027
Fezolinetant for treating vasomotor symptoms associated with the menopause [ID5071]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Women’s and reproductive health guidelinesStatus:In developmentProgramme:NICE HubExpected publication date: TBC